Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lippia citriodora + hibiscus sabdariffa
- Development stage
- Preclinical
- Lead developer
- Monteloeder
- Administration
- Oral
01
Overview
A combination of polyphenolic extracts from Lippia citriodora (lemon verbena) and Hibiscus sabdariffa that has been studied for weight management, metabolic health, and appetite regulation. The combination works primarily by modulating AMPK activity, normalizing leptin levels, and providing antioxidant and anti-inflammatory effects.
- Brand names
- Metabolaid
- Other names
- LC-HS
02
Targets
LEPR (Leptin receptor)AMPK (Adenosine monophosphate–activated protein kinase)
Beyond the preview
Go deeper on lippia citriodora + hibiscus sabdariffa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lippia citriodora + hibiscus sabdariffa.